Several proteins can traverse biological membranes through protein transduc
tion. Small sections of these proteins (10-16 residues long;) are responsib
le for this. Linking these domains covalently to compounds, peptides, antis
ense peptide nucleic acids or 40-nm iron beads, or as in-frame fusions with
full-length proteins, lets them enter any cell type in a receptor- and tra
nsporter-independent fashion. Moreover, several of these fusions, introduce
d into mice, were delivered to all tissues, even crossing the blood-brain b
arrier. These domains thus might let us address new questions and evert hel
p in the treatment of human disease.